SCNI

Conviction 0HealthcareScan · Thu, Sep 24, 2026

Scinai Immunotherapeutics Ltd. (SCNI) closed at $1.88 (-5.05%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 46, RS Rating 3, -88.5% from its 52-week high, -74.2% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).

SCNI$1.88-5.05%

ResistanceSupportVol 14

Vol MA14 4.63M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Scinai Immunotherapeutics Ltd.Biological Products, (No Diagnostic Substances)www.scinai.com ↗

Price1.88

Change-5.05%

Gap-8.08%

Rel volume0.02×

Avg volume3.34M

Avg $ vol7.24M

SMA 201.96

SMA 502.34

SMA 2005.46

Price vs 50-19.69%

Price vs 200-65.57%

MA stackbearish

50/200 cross—

Supertrenddown · 2.49

RSI (14)46

MACD hist0.03

MACD crossbull · 1d

Stoch %K / %D36 / 40

ADX (14)14

+DI / −DI27 / 22

RSI divergence—

MACD divergence—

ATR %17.96%

ADR %12.85%

52w high16.30

52w low1.52

From 52w high-88.47%

Above 52w low+23.68%

New 52w highNo

SqueezeOff

Bollinger width76.12%

%B0.45

Donchian pos29.03%

Donchian high2.98

Donchian low1.43

AVWAP (52w high)3.60

vs AVWAP high-47.79%

AVWAP (52w low)1.70

vs AVWAP low+10.60%

OBV trendUp

Chaikin MF (20)-0.08

Today vs 20d0.02×

Avg vol (14d)4.63M

Avg vol (20d)3.34M

Avg $ vol (20d)7.24M

Market cap1.31M

RS Rating3 / 99

RS 3m (vs SPY)-30.77%

RS 6m (vs SPY)-88.76%

RS line new highNo

Trend template0/8

Technical rank11.2

1 week+16.05%

1 month-34.72%

3 months-26.27%

6 months-71.94%

1 year-86.07%

YTD-74.23%

P/E—

P/B—

P/S—

P/FCF—

EPS-0.0100

Div yield—

ROE120.50%

ROA-24.88%

Debt/Eq-0.08

Current4.28

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth29.37%

Price target—

Target upside—

Analyst rating—

Institutional0.00%

Ent. value—

Revenue—

Net income-3.52M

Gross profit—

Free cash flow-8.1M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out3.96M

Employees45

ListedTue, May 12, 2015

Free float488.73K

Float %72.1%

Short interest8.24K

Days to cover0.1d

Short volume35.2%

Squeeze score4 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank11.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.69

Support1.52

Days since event—

Candle confirm—

Financials as of Fri, Mar 31, 2023 · quarterly.

Congress activity

Disclosed STOCK Act trades in SCNI

All disclosures →

No recent disclosed trades by Congress in SCNI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCNI

Insider	Side	Shares	Value	Traded	Filed
Reichman Amir Chief Executive Officer · Ordinary Shares · 2026-06-16	Grant	400M	—	2026-06-16	2026-06-18
GERMAIN MARK Director · Ordinary Shares · 2026-06-16	Grant	120M	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in SCNI · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

SCNI

Recent news

Get daily signals & real-time alerts.